
DNA vs GRML
$DNA vs $GRML head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs GRML: the quick read
- ·DNA is the larger company by market cap ($875M vs $39M).
- ·GRML has been more active on our scanner (480 vs 366 alerts in 30 days).
- ·GRML has the smaller float (7.6M vs 62.0M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 480 and 366 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: DNA is more than 22x the market cap of GRML, so the same dollar of news moves GRML far harder.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and GRML on TheDesperateTrader.
- Is DNA or GRML the better stock?
- "Better" depends on your goal, and these two are not alike. DNA is the larger company by market cap ($875M vs $39M). GRML has been more active on our scanner (480 vs 366 alerts in 30 days). GRML has the smaller float (7.6M vs 62.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and GRML?
- The differences that matter: DNA is roughly 22x the size of the other by market cap ($875M vs $39M); they trade at very different share prices ($13.02 vs $5.12); DNA sits at 60% of its 52-week range against 27% for GRML; our scanner flagged DNA 366 times in the last 30 days against 480 for GRML. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and GRML is more active right now?
- Right now DNA is at about 1.8x its normal volume and GRML is at about 0.2x, so DNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or GRML? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and GRML comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.